Institutional information

China: manufacturing and supply chains

Explore published industry sources and prepare a quotation for your destination.

What to review

The linked industry disclosures describe their named companies and reporting periods. Confirm the manufacturer, dispatch origin and export documents for your own quotation.

Prepare your inquiry

Include the product or sequence, configuration, quantity, destination and required documents. The team can then review the scope and confirm the available information.

Sources and verification scope

Corporate disclosure · S07

Eli Lilly and Company Form 10-K, fiscal year 2025 ↗

SEC · filing by Eli Lilly and Company

Source details (original language)
Scope
Lilly reports reliance on China-based suppliers for portions of its supply chain
Document section
Manufacturing and supply, p. 21; third-party supply chain risk factors
Limitations
Does not identify Bolang, peptide purchases from Bolang, partnership, endorsement or certification.
Claim verification date
2026-09-09
Corporate disclosure · S08

WuXi AppTec expands global manufacturing capacity ↗

WuXi AppTec

Source details (original language)
Scope
Corporate statement: >100,000 L at end of 2025; expansion toward 130,000 L
Document section
SPPS reactor volume paragraph
Limitations
WuXi AppTec capacity only; target is not installed capacity. Not WuXi Biologics or Bolang.
Claim verification date
2026-09-09
Corporate disclosure · S11

Notícias: cooperação e presença global ↗

Chemitex

Source details (original language)
Scope
Chemitex reports cooperation with Zhejiang Jiuzhou
Document section
Cooperation announcement and Presença Global em 2025
Limitations
Self-reported cooperation, not transaction-level customs evidence. Geographic wording was not repeated.
Claim verification date
2026-09-09